Table 1 Clinic information of patients in the study
From: Endoscopic injection sclerotherapy for treating recurrent bleeding of small bowel angioectasias
Variables | Total cohort (n = 66) | Control group (n = 35) | EIS group (n = 31) | P-value |
|---|---|---|---|---|
Age (years) | ||||
Mean ± SD, range | 62.76 ± 10.89, 42–85 | 65.86 ± 12.23, 44–85 | 59.26 ± 7.96, 42–74 | 0.011* |
>65 | 23 (34.85) | 18 (51.43) | 5 (16.13) | 0.003* |
≤ 65 | 43 (65.15) | 17 (48.57) | 26 (83.87) | |
Sex, n (%) | ||||
Male | 31 (46.97) | 12 (34.29) | 19 (61.29) | 0.028* |
Female | 35 (53.03) | 23 (65.71) | 12 (38.71) | |
History of smoking, n (%) | 15 (22.73) | 6 (17.14) | 9 (29.03) | 0.250 |
History of drinking, n (%) | 8 (12.12) | 2 (5.71) | 6 (19.35) | 0.188 |
Drug use of antithrombotic, n (%) | 8 (12.12) | 5 (14.29) | 3 (9.68) | 0.846 |
Personal history of malignancy, n (%) | 5 (7.58) | 1 (2.86) | 4 (12.90) | 0.283 |
History of gastrointestinal surgery, n (%) | 6 (9.09) | 4 (11.43) | 2 (6.45) | 0.785 |
Hospitalization before admission, n (%) | 49 (74.24) | 26 (74.29) | 23 (74.19) | 0.993 |
RBC transfusion before admission, n (%) | 43 (65.15) | 21 (60.00) | 22 (70.97) | 0.351 |
LOS (days) | ||||
Mean ± SD | 9.00 ± 1.77 | 9.49 ± 1.99 | 8.45 ± 1.31 | 0.015* |
Median (range) | 9 (6–14) | 9 (6–14) | 8 (6–11) | |
Underlying diseases, n(%) | ||||
Hypertension | 42 (63.64) | 22 (62.86) | 20 (64.52) | 0.889 |
Cardiovascular disease | 4 (6.06) | 1 (2.86) | 3 (9.68) | 0.521 |
Chronic renal failure | 2 (3.03) | 1 (2.86) | 1 (3.23) | >0.999 |
Diabetes | 4 (6.06) | 0 (0.00) | 4 (12.90) | 0.094 |
Liver cirrhosis | 8 (12.12) | 2 (5.71) | 6 (19.35) | 0.188 |